MX9707269A - Un metodo de tratamiento de mania y desorden bipolar. - Google Patents

Un metodo de tratamiento de mania y desorden bipolar.

Info

Publication number
MX9707269A
MX9707269A MX9707269A MX9707269A MX9707269A MX 9707269 A MX9707269 A MX 9707269A MX 9707269 A MX9707269 A MX 9707269A MX 9707269 A MX9707269 A MX 9707269A MX 9707269 A MX9707269 A MX 9707269A
Authority
MX
Mexico
Prior art keywords
treatment
mania
bipolar disorder
gabapentin
recurrent
Prior art date
Application number
MX9707269A
Other languages
English (en)
Other versions
MXPA97007269A (es
Inventor
Atul Chandra Pande
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MX9707269A publication Critical patent/MX9707269A/es
Publication of MXPA97007269A publication Critical patent/MXPA97007269A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invencion es un uso terapéutico novedoso de gabapentina, sus derivados y las sales farmacéuticas del mismo. Los compuestos son utiles en el tratamiento de manía en todas sus varia formas ya sean agudas o cronicas,unicas o recurrentes y si o no esté asociada con depresion. La invencion incluye además el tratamiento preventivo del desorden bipolar.
MXPA/A/1997/007269A 1995-05-15 1997-09-23 Un metodo de tratamiento de mania y desordenbipolar MXPA97007269A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08440570 1995-05-15
US08/440,570 US5510381A (en) 1995-05-15 1995-05-15 Method of treatment of mania and bipolar disorder
PCT/US1996/005898 WO1996036328A1 (en) 1995-05-15 1996-04-26 A method of treatment of mania and bipolar disorder

Publications (2)

Publication Number Publication Date
MX9707269A true MX9707269A (es) 1997-11-29
MXPA97007269A MXPA97007269A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
ES2177783T3 (es) 2002-12-16
SK281982B6 (sk) 2001-09-11
CZ355897A3 (cs) 1998-02-18
EE03420B1 (et) 2001-06-15
ZA963826B (en) 1996-11-21
EE9700302A (et) 1998-06-15
CA2215923C (en) 2001-10-09
HUP9802087A2 (hu) 1998-12-28
PT825857E (pt) 2002-11-29
NZ307366A (en) 1999-10-28
JPH11505244A (ja) 1999-05-18
CA2215923A1 (en) 1996-11-21
EP0825857A1 (en) 1998-03-04
EP0825857B1 (en) 2002-06-12
NO975234L (no) 1997-11-14
AU702435B2 (en) 1999-02-18
DE69621799D1 (de) 2002-07-18
GEP20002014B (en) 2000-04-10
DE69621799T2 (de) 2003-01-02
ATE218857T1 (de) 2002-06-15
CZ288072B6 (cs) 2001-04-11
NO975234D0 (no) 1997-11-14
DK0825857T3 (da) 2002-09-30
SK152897A3 (en) 1999-05-07
WO1996036328A1 (en) 1996-11-21
AU5668996A (en) 1996-11-29
NO315967B1 (no) 2003-11-24
HUP9802087A3 (en) 1999-08-30
US5510381A (en) 1996-04-23

Similar Documents

Publication Publication Date Title
ZA963826B (en) A method of treatment of mania and bipolar disorder
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
MY112915A (en) Multiple unit tableted dosage form 1
CA2258895A1 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
ID28003A (id) Turunan-turunan adamantana
EP0648492A3 (en) Inhibition of phosphatidylinositol-3-kinase with viridin, dimethoxyviridin, viridiol, dimethoxyviridiol, virone, wortmannolone, and their derivatives.
EP0347864A3 (en) Anti-atherogenic agents
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
GR3020869T3 (en) Immediate-effect flurbiprofen-containing medicament and its use.
HUP9901990A3 (en) Furan- and thiophene derivatives having inhibitor effect on the replication of hiv-1 and hiv-1 mutants, and medicaments containing the same
WO1998022099A3 (en) New use of creatine
IL126161A0 (en) Method for treating autism
FI953622A (fi) Ifenprodiilin ja sen diastereoisomeerien käyttö lääkeaineiden valmistukseen, jotka lääkeaineet ovat käyttökelpoisia perifeeristen neuropatiatilojen ja keskushermoston degeneratiivisten sairauksien hoitoon
DE59608611D1 (de) Topische aciclovir-zubereitung
NO981320L (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
YU40098A (sh) Upotreba olanzapina za dobijanje leka
MX9801515A (es) Preparado de combinacion para la aplicacion en la demencia.
SI0825857T1 (en) Use of gabapentin and its derivatives in the treatment of mania and bipolar disorder
IL128768A0 (en) Transdermal therapeutic system containing oestriol
MX9701294A (es) Un medicamento que contiene un derivado de carnitina para el tratamiento de la arterioesclerosis cronica obliteradora.
ES2139382T3 (es) Sistema terapeutico percutaneo para compuestos de silatran.
ATE179987T1 (de) Vitamin b 12-haltige sanddornkonzentrate oder - extrakte
JO1880B1 (en) Format 1 for multi-unit calibration discs